{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:48:08Z","timestamp":1782222488662,"version":"3.54.5"},"reference-count":48,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,23]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Sickle cell disease (SCD), caused by a point mutation in the \u03b2-globin gene (HBB), results in the production of sickle hemoglobin (HbS). Deoxy-HbS polymerizes, deforming red blood cells (RBCs) and leading to a cascade of clinical complications, including vaso-occlusion, hemolysis, inflammation, and progressive organ damage. An effective strategy to mitigate disease severity is the reactivation of fetal hemoglobin (HbF), which interferes with HbS polymerization. We explored the therapeutic potential of ZLN005, a small-molecule activator of the transcriptional coactivator PGC-1\u03b1 (peroxisome proliferator\u2013activated receptor gamma coactivator 1-\u03b1), by evaluating its impact on HbF induction in CD34+ hematopoietic progenitor cells derived from patients with SCD, in \u03b2-YAC transgenic mice carrying a normal human HBB cluster, and in SCD mice. ZLN005 increased \u03b3-globin expression and HbF+ cells without impairing erythroid differentiation of CD34+ cells. Oral administration of ZLN005 to SCD mice increased HbF+ cells, reduced sickled RBCs, increased hemoglobin levels, lowered reticulocyte counts, and decreased spleen and liver pathology related to SCD. ZLN005 or related compounds could represent a promising new class of orally available HbF-inducing therapeutics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025018409","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:54:50Z","timestamp":1776959690000},"page":"4358-4369","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["PGC-1\u03b1 agonism via oral administration of ZLN005 induces fetal hemoglobin and is antisickling in sickle mice"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7830-9436","authenticated-orcid":false,"given":"Hajar","family":"Benmhammed","sequence":"first","affiliation":[{"name":"1Department of Medicine, Section of Hematology-Medical Oncology, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Sun","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Section of Hematology-Medical Oncology, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9815-3256","authenticated-orcid":false,"given":"Salam","family":"AlAbdullatif","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Section of Computational Biomedicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Chen","sequence":"additional","affiliation":[{"name":"3Department of Human Physiology, Sargent College of Health and Rehabilitation Sciences, Boston University, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5509-2336","authenticated-orcid":false,"given":"Serena","family":"Khan","sequence":"additional","affiliation":[{"name":"3Department of Human Physiology, Sargent College of Health and Rehabilitation Sciences, Boston University, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anais Mortazavi","family":"Zadeh","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Section of Hematology-Medical Oncology, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noundy","family":"Mazile","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Section of Hematology-Medical Oncology, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7158-6887","authenticated-orcid":false,"given":"Gwendolyn M.","family":"Beacham","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Section of Hematology-Medical Oncology, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiana","family":"Mahdaviani","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Section of Hematology-Medical Oncology, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Williams","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Section of Computational Biomedicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6105-8861","authenticated-orcid":false,"given":"Yuriy O.","family":"Alekseyev","sequence":"additional","affiliation":[{"name":"4Department of Pathology and Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0780-8662","authenticated-orcid":false,"given":"Joshua D.","family":"Campbell","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Section of Computational Biomedicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3824-3249","authenticated-orcid":false,"given":"Elliott J.","family":"Hagedorn","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Section of Hematology-Medical Oncology, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4264-1810","authenticated-orcid":false,"given":"Christopher","family":"Heaphy","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Section of Hematology-Medical Oncology, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth S.","family":"Klings","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Section of Hematology-Medical Oncology, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8800-8020","authenticated-orcid":false,"given":"Martin H.","family":"Steinberg","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Section of Hematology-Medical Oncology, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9104-8517","authenticated-orcid":false,"given":"Shuaiying","family":"Cui","sequence":"additional","affiliation":[{"name":"1Department of Medicine, Section of Hematology-Medical Oncology, Boston University Chobanian & Avedisian School of Medicine, Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"2026062308480391600_bib1","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1100\/tsw.2008.157","article-title":"Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches","volume":"8","author":"Steinberg","year":"2008","journal-title":"ScientificWorldJournal"},{"issue":"16","key":"2026062308480391600_bib2","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJMra1510865","article-title":"Sickle cell disease","volume":"376","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"2026062308480391600_bib3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1177\/1535370216636726","article-title":"Minireview: genetic basis of heterogeneity and severity in sickle cell disease","volume":"241","author":"Habara","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"key":"2026062308480391600_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-4939-7299-9_7","article-title":"Reactivation of fetal hemoglobin for treating \u03b2-thalassemia and sickle cell disease","volume":"1013","author":"Cui","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"18","key":"2026062308480391600_bib5","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJMoa2309676","article-title":"Exagamglogene autotemcel for severe sickle cell disease","volume":"390","author":"Frangoul","year":"2024","journal-title":"N Engl J Med"},{"issue":"4","key":"2026062308480391600_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood-2013-09-528067","article-title":"Fetal hemoglobin in sickle cell anemia: a glass half full?","volume":"123","author":"Steinberg","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2026062308480391600_bib7","doi-asserted-by":"crossref","first-page":"21997","DOI":"10.1038\/s41598-023-48919-3","article-title":"An \u03b1-chain modification rivals the effect of fetal hemoglobin in retarding the rate of sickle cell fiber formation","volume":"13","author":"Worth","year":"2023","journal-title":"Sci Rep"},{"issue":"2","key":"2026062308480391600_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2141.2011.08916.x","article-title":"Fetal haemoglobin levels and haematological characteristics of compound heterozygotes for haemoglobin S and deletional hereditary persistence of fetal haemoglobin","volume":"156","author":"Ngo","year":"2012","journal-title":"Br J Haematol"},{"issue":"3","key":"2026062308480391600_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/MOH.0b013e32834521dd","article-title":"Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain?","volume":"18","author":"McGann","year":"2011","journal-title":"Curr Opin Hematol"},{"issue":"7","key":"2026062308480391600_bib10","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/ajh.26956","article-title":"An integrated therapeutic approach to sickle cell disease management beyond infancy","volume":"98","author":"Ribeil","year":"2023","journal-title":"Am J Hematol"},{"issue":"7","key":"2026062308480391600_bib11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2117175","article-title":"Biologic and clinical efficacy of LentiGlobin for sickle cell disease","volume":"386","author":"Kanter","year":"2022","journal-title":"N Engl J Med"},{"issue":"3","key":"2026062308480391600_bib12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"2026062308480391600_bib13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(00)81410-5","article-title":"A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis","volume":"92","author":"Puigserver","year":"1998","journal-title":"Cell"},{"issue":"9","key":"2026062308480391600_bib14","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00125-015-3671-z","article-title":"The hitchhiker's guide to PGC-1\u03b1 isoform structure and biological functions","volume":"58","author":"Martinez-Redondo","year":"2015","journal-title":"Diabetologia"},{"issue":"6","key":"2026062308480391600_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmet.2005.05.004","article-title":"Metabolic control through the PGC-1 family of transcription coactivators","volume":"1","author":"Lin","year":"2005","journal-title":"Cell Metab"},{"issue":"11","key":"2026062308480391600_bib16","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1128\/MCB.00247-14","article-title":"PGC-1 coactivator activity is required for murine erythropoiesis","volume":"34","author":"Cui","year":"2014","journal-title":"Mol Cell Biol"},{"issue":"3","key":"2026062308480391600_bib17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood-2015-02-626259","article-title":"The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice","volume":"126","author":"Cui","year":"2015","journal-title":"Blood"},{"issue":"4","key":"2026062308480391600_bib18","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2337\/db12-0703","article-title":"Novel small-molecule PGC-1\u03b1 transcriptional regulator with beneficial effects on diabetic db\/db mice","volume":"62","author":"Zhang","year":"2013","journal-title":"Diabetes"},{"issue":"1","key":"2026062308480391600_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bjh.18042","article-title":"Pharmacologic induction of PGC-1\u03b1 stimulates fetal haemoglobin gene expression","volume":"197","author":"Sun","year":"2022","journal-title":"Br J Haematol"},{"issue":"4","key":"2026062308480391600_bib20","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1182\/blood-2006-02-004812","article-title":"Correction of sickle cell disease by homologous recombination in embryonic stem cells","volume":"108","author":"Wu","year":"2006","journal-title":"Blood"},{"issue":"31","key":"2026062308480391600_bib21","doi-asserted-by":"crossref","first-page":"eadn8750","DOI":"10.1126\/sciadv.adn8750","article-title":"PGC-1\u03b1 agonism induces fetal hemoglobin and exerts antisickling effects in sickle cell disease","volume":"10","author":"Sun","year":"2024","journal-title":"Sci Adv"},{"issue":"4","key":"2026062308480391600_bib22","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1182\/blood-2007-01-068635","article-title":"Developmental- and differentiation-specific patterns of human \u03b3- and \u03b2-globin promoter DNA methylation","volume":"110","author":"Mabaera","year":"2007","journal-title":"Blood"},{"issue":"8","key":"2026062308480391600_bib23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1182\/blood.2023022190","article-title":"Elevating fetal hemoglobin: recently discovered regulators and mechanisms","volume":"144","author":"Khandros","year":"2024","journal-title":"Blood"},{"issue":"3","key":"2026062308480391600_bib24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.exphem.2004.11.007","article-title":"Control of globin gene expression during development and erythroid differentiation","volume":"33","author":"Stamatoyannopoulos","year":"2005","journal-title":"Exp Hematol"},{"issue":"5909","key":"2026062308480391600_bib25","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1126\/science.1165409","article-title":"Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A","volume":"322","author":"Sankaran","year":"2008","journal-title":"Science"},{"issue":"6155","key":"2026062308480391600_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1126\/science.1242088","article-title":"An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level","volume":"342","author":"Bauer","year":"2013","journal-title":"Science"},{"issue":"2","key":"2026062308480391600_bib27","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.cell.2018.03.016","article-title":"Direct promoter repression by BCL11A controls the fetal to adult hemoglobin switch","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"6270","key":"2026062308480391600_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.aad3312","article-title":"Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin","volume":"351","author":"Masuda","year":"2016","journal-title":"Science"},{"issue":"4","key":"2026062308480391600_bib29","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41588-018-0085-0","article-title":"Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding","volume":"50","author":"Martyn","year":"2018","journal-title":"Nat Genet"},{"issue":"11","key":"2026062308480391600_bib30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1182\/bloodadvances.2016002303","article-title":"KLF1 directly activates expression of the novel fetal globin repressor ZBTB7A\/LRF in erythroid cells","volume":"1","author":"Norton","year":"2017","journal-title":"Blood Adv"},{"issue":"9","key":"2026062308480391600_bib31","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/ng.637","article-title":"KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching","volume":"42","author":"Zhou","year":"2010","journal-title":"Nat Genet"},{"issue":"9","key":"2026062308480391600_bib32","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ng.630","article-title":"Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin","volume":"42","author":"Borg","year":"2010","journal-title":"Nat Genet"},{"issue":"27","key":"2026062308480391600_bib33","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1073\/pnas.0611393104","article-title":"Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults","volume":"104","author":"Thein","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2026062308480391600_bib34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nm.3101","article-title":"Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction","volume":"19","author":"Shi","year":"2013","journal-title":"Nat Med"},{"issue":"22","key":"2026062308480391600_bib35","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1182\/blood.2018892737","article-title":"Inhibition of LSD1 by small molecule inhibitors stimulates fetal hemoglobin synthesis","volume":"133","author":"Le","year":"2019","journal-title":"Blood"},{"issue":"7","key":"2026062308480391600_bib36","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/ajh.24019","article-title":"Inactivation of HDAC1 or HDAC2 induces gamma globin expression without altering cell cycle or proliferation","volume":"90","author":"Esrick","year":"2015","journal-title":"Am J Hematol"},{"issue":"3","key":"2026062308480391600_bib37","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1182\/blood.2024028006","article-title":"Novel, potent, and orally bioavailable LSD1 inhibitors induce fetal hemoglobin synthesis in a sickle cell disease mouse model","volume":"146","author":"Wang","year":"2025","journal-title":"Blood"},{"issue":"1","key":"2026062308480391600_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.trsl.2014.05.002","article-title":"Epigenetic regulation of fetal globin gene expression in adult erythroid cells","volume":"165","author":"Ginder","year":"2015","journal-title":"Transl Res"},{"issue":"2","key":"2026062308480391600_bib39","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.molcel.2020.11.006","article-title":"ZNF410 Uniquely Activates the NuRD Component CHD4 to Silence Fetal Hemoglobin Expression","volume":"81","author":"Lan","year":"2021","journal-title":"Mol Cell"},{"issue":"14","key":"2026062308480391600_bib40","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1182\/bloodadvances.2019000375","article-title":"Gdf15 regulates murine stress erythroid progenitor proliferation and the development of the stress erythropoiesis niche","volume":"3","author":"Hao","year":"2019","journal-title":"Blood Adv"},{"issue":"20","key":"2026062308480391600_bib41","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia","volume":"332","author":"Charache","year":"1995","journal-title":"N Engl J Med"},{"issue":"3","key":"2026062308480391600_bib42","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood.V89.3.1078","article-title":"Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter study of hydroxyurea","volume":"89","author":"Steinberg","year":"1997","journal-title":"Blood"},{"issue":"23","key":"2026062308480391600_bib43","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"issue":"10091","key":"2026062308480391600_bib44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet"},{"issue":"10","key":"2026062308480391600_bib45","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"9861","key":"2026062308480391600_bib46","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"2026062308480391600_bib47","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1182\/blood-2005-09-008318","article-title":"The effect of fetal hemoglobin on the survival characteristics of sickle cells","volume":"108","author":"Franco","year":"2006","journal-title":"Blood"},{"issue":"2","key":"2026062308480391600_bib48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10739680490278402","article-title":"The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy","volume":"11","author":"Hebbel","year":"2004","journal-title":"Microcirculation"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/12\/4358\/2527677\/blooda_adv-2025-018409-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/12\/4358\/2527677\/blooda_adv-2025-018409-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:58:13Z","timestamp":1782219493000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/12\/4358\/567941\/PGC-1-agonism-via-oral-administration-of-ZLN005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,6,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025018409","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,23]]},"published":{"date-parts":[[2026,6,12]]}}}